USHIK Now Associates Domains With Meaningful Use Clinical Quality Measures
More than 70 percent of injury-related emergency department visits among persons age 65 and older in 2010 were related to falls. (Source: Agency for Healthcare Research and Quality, Healthcare Cost and Utilization Project Statistical Brief #156: Causes of Injuries Treated in the Emergency Department, 2010.)
- USHIK Now Associates Domains With Meaningful Use Clinical Quality Measures.
- AHRQ's Health Care Innovations Exchange Focuses on Using Decision Aids in Shared Decisionmaking.
- CHIPRA Evaluation Highlight Discusses Strategies for Improving Adolescent Health Care.
- New AHRQ Review Evaluates Tinnitus Treatment Options.
- AHRQ's Patient Safety Network Examines Clinical Training and Patient Safety for Medical Residents.
- AHRQ in the professional literature.
AHRQ's U.S. Health Information Knowledgebase (USHIK) Web site now lists all relevant core and menu objectives as well as Clinical Quality Measures (CQMs) that make up Stage 2 Meaningful Use Criteria. AHRQ's USHIK Meaningful Use Portal also allows users to view CQMs by domain and, for each individual CQM, to view the domain with which it is associated. The consolidated information helps eligible hospitals and professionals reduce the time and resources needed to implement validated and endorsed health quality measures. Select to access additional information. Data are made publicly available in USHIK by a federal partnership of AHRQ, CMS, NIH/National Library of Medicine, and the Office of the National Coordinator for Health Information Technology.
The latest issue of AHRQ's Health Care Innovations Exchange features two programs that promote shared decisionmaking through the use of decision aids. One of the featured profiles describes legislative efforts in Washington state to promote the routine use of shared decisionmaking, in which patients and physicians jointly decide on the best course of action based on available evidence and patient preferences and values. These laws are designed to reduce variations in care and improve quality by mandating implementation of a multisite demonstration project, recognizing use of decision aids as evidence of informed consent in malpractice cases, and creating a governor-appointed learning collaborative to identify variations in care delivery and evidence-based practices (including shared decisionmaking) for reducing such variations. The state has also proposed legislation to establish a certification process for shared decisionmaking tools. The demonstration project has identified success factors for and barriers to its routine use, and the learning collaborative has begun to establish shared decisionmaking as an evidence-based practice for reducing variations in care. Select to access more innovation profiles, tools, and resources related to shared decisionmaking and the use of patient decision aids on the Innovations Exchange Web site, which contains more than 800 searchable innovations and 1,525 quality tools.
The third Evaluation Highlight from the national evaluation of the Children's Health Insurance Program Reauthorization Act of 2009 (CHIPRA) Quality Demonstration Grant program is now available. This Highlight describes the actions selected demonstration states have taken to enhance adolescent health care, the barriers these states have encountered, and strategies for addressing these barriers. AHRQ is leading a national evaluation of the CHIPRA Quality Demonstration Grant Program, which aims to improve the quality of health care for children enrolled in Medicaid and CHIP. Select to access Evaluation Highlight No. 3: How are CHIPRA Quality Demonstration States working to improve adolescent health care? and to obtain more information on the CHIPRA Quality Demonstration Grant projects and the national evaluation.
A new AHRQ research review finds that, among pharmacological/food supplements, medical/surgical treatments, sound treatments/technologies, and psychological/behavioral treatments for tinnitus (ringing in the ears), there is low strength of evidence indicating that cognitive behavioral therapy interventions improve tinnitus-specific quality of life compared with inactive controls. According to the review, sertraline is the one pharmacological intervention with consistently significant effects on multiple outcomes in a clinical trial (e.g., reducing loudness, improving global quality of life, and alleviating severity). For pharmacological interventions overall, the strength of evidence is low that neurotransmitter drugs improve subjective loudness compared with placebo in tinnitus patients. The strength of evidence is insufficient for all other pharmacological interventions and outcomes, such as sleep disturbance, tinnitus-specific quality of life, and anxiety. There is not enough evidence to suggest that medical or sound technology interventions improve outcomes relative to inactive controls. Additional research is needed to investigate measures used to assess patients for management needs and the identification of prognostic factors. Select to access the research review, titled Evaluation and Treatment of Tinnitus: Comparative Effectiveness Review.
A patient safety primer on AHRQ's Patient Safety Network (PSNet) provides background on physician work hours and patient safety. The primer describes 2010 recommendations by the Accreditation Council for Graduate Medical Education to reduce extended work shifts for first-year physicians and increase oversight by more senior physicians. It also suggests that if duty hours are further reduced, simulation training may be a viable alternative to improve residents' technical, cognitive, and teamwork skills. Select to access the full patient safety primer, titled “Physician Work Hours and Patient Safety.”
Berg LJ, Delgado MK, Ginde AA, et al. Characteristics of U.S. emergency departments that offer routine human immunodeficiency virus screening. Acad Emerg Med. 2012 Aug;19(8):894-900. Epub 2012 July 31. Select to access the abstract on PubMed®.
Nundy S, Dick JJ, Solomon MC, et al. Developing a behavioral model for mobile phone-based diabetes interventions. Patient Educ Couns. 2013 Jan;90(1):125-32. Epub 2012 Oct 10. Select to access the abstract on PubMed®.
Holden RJ, Brown RL, Scanlon MC, et al. Pharmacy workers' perceptions and acceptance of bar-coded medication technology in a pediatric hospital. Res Social Adm Pharm. 2012 Nov-Dec;8(6):509-22. Epub 2012 Mar 13. Select to access the abstract on PubMed®.
Breslin TM, Banerjee M, Gust C, et al. Trends in advanced imaging use for women undergoing breast cancer surgery. Cancer. 2013 Mar 15;119(6):1251-6. Epub 2012 Dec 4. Select to access the abstract on PubMed®.
Tropello SP, Ravitz AD, Romig M, et al. Enhancing the quality of care in the intensive care unit: a systems engineering approach. Crit Care Clin. 2013 Jan;29(1):113-24. Select to access the abstract on PubMed®.
Putzer GJ, Koro-Ljungberg M, Duncan RP. Critical challenges and impediments affecting rural physicians during a public health emergency. Disaster Med Public Health Prep. 2012 Dec;6(4):342-8. Select to access the abstract on PubMed®.
Nundy S, Dick JJ, Goddu AP, et al. Using mobile health to support the chronic care model: developing an institutional initiative. Int J Telemed Appl. 2012;2012:871925. Epub 2012 Dec 5. Select to access the abstract on PubMed®.
O'Neil CK, Hanlon JT, Marcum ZA. Adverse effects of analgesics commonly used by older adults with osteoarthritis: focus on non-opioid and opioid analgesics. Am J Geriatr Pharmacother. 2012 Dec;10(6):331-42. Epub 2012 Oct 2. Select to access the abstract on PubMed®.
Please address comments and questions regarding the AHRQ Electronic Newsletter to Linwood Norman at Linwood.Norman@ahrq.hhs.gov or (301) 427-1248..
Update your subscriptions, modify your password or email address, or stop subscriptions at any time on your Subscriber Preferences Page. You will need to use your email address to log in.
If you have any questions or problems with the subscription service, email: email@example.com. For other inquiries, Contact Us.
This service is provided to you at no charge by the Agency for Healthcare Research and Quality (AHRQ).